» Articles » PMID: 36534439

Fibrotic Lung Disease Alters Neutrophil Trafficking and Promotes Neutrophil Elastase and Extracellular Trap Release

Overview
Journal Immunohorizons
Date 2022 Dec 19
PMID 36534439
Authors
Affiliations
Soon will be listed here.
Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive, irreversible disease characterized by collagen deposition within the interstitium of the lung. This impairs gas exchange and results in eventual respiratory failure. Clinical studies show a correlation between elevated neutrophil numbers and IPF disease progression; however, the mechanistic roles neutrophils play in this disease are not well described. In the present study, we describe alterations to the trafficking and function of neutrophils after the development of fibrosis. We observed increased numbers of total and aged neutrophils in peripheral tissues of fibrotic mice. This appeared to be driven by an upregulation of neutrophil chemokine Cxcl2 by lung cells. In addition, neutrophil recruitment back to the bone marrow for clearance appeared to be impaired, because we saw decreased aged neutrophils in the bone marrow of fibrotic mice. Neutrophils in fibrosis were activated, because ex vivo assays showed increased elastase and extracellular trap release by neutrophils from fibrotic mice. This likely mediated disease exacerbation, because mice exhibiting a progressive disease phenotype with greater weight loss and mortality had more activated neutrophils and increased levels of extracellular DNA present in their lungs than did mice with a nonprogressive disease phenotype. These findings further our understanding of the dynamics of neutrophil populations and their trafficking in progressive fibrotic lung disease and may help inform treatments targeting neutrophil function for patients with IPF experiencing disease exacerbation in the future.

Citing Articles

The Chemokine System as a Key Regulator of Pulmonary Fibrosis: Converging Pathways in Human Idiopathic Pulmonary Fibrosis (IPF) and the Bleomycin-Induced Lung Fibrosis Model in Mice.

Russo R, Ryffel B Cells. 2025; 13(24).

PMID: 39768150 PMC: 11674266. DOI: 10.3390/cells13242058.


Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives.

Crowley L, Stockley R, Thickett D, Dosanjh D, Scott A, Parekh D Eur Respir Rev. 2024; 33(174).

PMID: 39603661 PMC: 11600124. DOI: 10.1183/16000617.0139-2024.


Opposite effects of systemic and local conditional CD11c+ myeloid cell depletion during bleomycin-induced inflammation and fibrosis in mice.

Lopes G, Lima B, Freitas C, Peixoto A, Soriani F, Cassali G Immun Inflamm Dis. 2024; 12(11):e70042.

PMID: 39582275 PMC: 11586507. DOI: 10.1002/iid3.70042.


Immune mechanisms in fibrotic interstitial lung disease.

Kamiya M, Carter H, Espindola M, Doyle T, Lee J, Merriam L Cell. 2024; 187(14):3506-3530.

PMID: 38996486 PMC: 11246539. DOI: 10.1016/j.cell.2024.05.015.


Cell-Free DNA Maps Tissue Injury and Correlates with Disease Severity in Lung Transplant Candidates.

Balasubramanian S, Richert M, Kong H, Fu S, Jang M, Andargie T Am J Respir Crit Care Med. 2023; 209(6):727-737.

PMID: 38117233 PMC: 10945061. DOI: 10.1164/rccm.202306-1064OC.


References
1.
Manoury B, Nenan S, Guenon I, Lagente V, Boichot E . Influence of early neutrophil depletion on MMPs/TIMP-1 balance in bleomycin-induced lung fibrosis. Int Immunopharmacol. 2007; 7(7):900-11. DOI: 10.1016/j.intimp.2007.02.009. View

2.
Xu-Vanpala S, Deerhake M, Wheaton J, Parker M, Juvvadi P, MacIver N . Functional heterogeneity of alveolar macrophage population based on expression of CXCL2. Sci Immunol. 2020; 5(50). PMC: 7717592. DOI: 10.1126/sciimmunol.aba7350. View

3.
Gregory A, Kliment C, Metz H, Kim K, Kargl J, Agostini B . Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis. J Leukoc Biol. 2015; 98(2):143-52. PMC: 4763951. DOI: 10.1189/jlb.3HI1014-493R. View

4.
Bryant A, Shenoy V, Fu C, Marek G, Lorentsen K, Herzog E . Myeloid-derived Suppressor Cells Are Necessary for Development of Pulmonary Hypertension. Am J Respir Cell Mol Biol. 2017; 58(2):170-180. PMC: 5805999. DOI: 10.1165/rcmb.2017-0214OC. View

5.
Veglia F, Perego M, Gabrilovich D . Myeloid-derived suppressor cells coming of age. Nat Immunol. 2018; 19(2):108-119. PMC: 5854158. DOI: 10.1038/s41590-017-0022-x. View